Home  »  Company   »  Edwards Lifesciences Corporation (EW): What Are Th...

Edwards Lifesciences Corporation (EW): What Are The Positives?

Edwards Lifesciences Corporation (NYSE:EW) has a beta value of 1.03 and has seen 0.97 million shares traded in the recent trading session. The company, currently valued at $45.14B, closed the recent trade at $75.81 per share which meant it gained $1.5 on the day or 2.01% during that session. The EW stock price is -73.76% off its 52-week high price of $131.73 and 11.45% above the 52-week low of $67.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.43 million shares traded. The 3-month trading volume is 4.21 million shares.

Edwards Lifesciences Corporation (NYSE:EW) trade information

Sporting 2.01% in the green today, the stock has traded in the red over the last five days, with the highest price hit on Tuesday, 11/22/22 when the EW stock price touched $75.81 or saw a rise of 0.11%. Year-to-date, Edwards Lifesciences Corporation shares have moved -42.64%, while the 5-day performance has seen it change -2.17%. Over the past 30 days, the shares of Edwards Lifesciences Corporation (NYSE:EW) have changed -12.48%. Short interest in the company has seen 7.45 million shares shorted with days to cover at 2.82.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Edwards Lifesciences Corporation (EW) estimates and forecasts

Figures show that Edwards Lifesciences Corporation shares have outperformed across the wider relevant industry. The company’s shares have lost -21.40% over the past 6 months, with this year growth rate of 10.36%, compared to 0.40% for the industry. Other than that, the company has, however, increased its growth outlook for the 2022 fiscal year revenue. Growth estimates for the current quarter are 29.40% and 10.00% for the next quarter. Revenue growth from the last financial year stood is estimated to be 4.40%.

20 analysts offering their estimates for the company have set an average revenue estimate of $1.41 billion for the current quarter. 13 have an estimated revenue figure of $1.45 billion for the next quarter concluding in Mar 2023. Year-ago sales stood $1.33 billion and $1.34 billion respectively for this quarter and the next, and analysts expect sales will grow by 5.80% for the current quarter and 7.90% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 22.30% over the past 5 years. Earnings growth for 2022 is a modest 82.80% while over the next 5 years, the company’s earnings are expected to increase by 10.64%.

EW Dividends

Edwards Lifesciences Corporation is expected to release its next earnings report between January 24 and January 30 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Edwards Lifesciences Corporation (NYSE:EW)’s Major holders

Insiders own 0.81% of the company shares, while shares held by institutions stand at 84.67% with a share float percentage of 85.36%. Investors are also buoyed by the number of investors in a company, with Edwards Lifesciences Corporation having a total of 1,762 institutions that hold shares in the company. The top two institutional holders are Blackrock Inc. with over 55.74 million shares worth more than $5.3 billion. As of Jun 29, 2022, Blackrock Inc. held 8.99% of shares outstanding.

The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 50.31 million shares as of Jun 29, 2022. The firm’s total holdings are worth over $4.78 billion and represent 8.11% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. As of Jun 29, 2022, the former fund manager holds about 2.95% shares in the company for having 18.31 million shares of worth $1.74 billion while later fund manager owns 13.76 million shares of worth $1.31 billion as of Jun 29, 2022, which makes it owner of about 2.22% of company’s outstanding stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts